Biomedical Engineering Reference
In-Depth Information
20. Hiki S, Kataoka K (2007) A facile synthesis of azido-terminated heterobifunctional poly
(ethylene glycol)s for “click” conjugation. Bioconjug Chem 18:2191-2196
21. Hiki S, Kataoka K (2010) Versatile and selective synthesis of “click chemistry” compatible
heterobifunctional poly(ethylene glycol)s possessing azide and alkyne functionalities.
Bioconjug Chem 21:248-254
22. Pasut G, Veronese FM (2007) Polymer-drug conjugation, recent achievements and general
strategies. Progr Polym Sci 32:933-961
23. Zhao H, Yang K, Martinez A, Basu A, Chintala R, Liu HC, Janjua A, Wang M, Filpula D
(2006) Linear and branched bicin linkers for releasable PEGylation of macromolecules:
controlled release in vivo and in vitro from mono- and multi-PEGylated proteins. Bioconjug
Chem 17:341-351
24. Veronese FM, Caliceti P, Schiavon O (1997) Branched and linear poly(ethylene glycol):
Influence of the polymer structure on enzymological, pharmacokinetic and immunological
properties of proteinconjugates. J Bioact Compatible Polym 12:196-207
25. Aghemo A, Rumi MG, Colombo M (2010) Pegylated interferons alpha2a and alpha2b in the
treatment of chronic hepatitis C. Nat Rev Gastroenterol Hepatol 7:485-494
26. Campa C, Harding SP (2011) Anti-VEGF compounds in the treatment of neovascular age
related macular degeneration. Curr Drug Targets 12:173-181
27. Patel AM, Moreland LW (2010) Certolizumab pegol: a new biologic targeting rheumatoid
arthritis. Expert Rev Clin Immunol 6:855-866
28. Fee CJ (2007) Size comparison between proteins PEGylated with branched and linear poly
(ethylene glycol) molecules. Biotechnol Bioeng 98:725-731
29. Veronese FM, Schiavon O, Pasut G, Mendichi R, Andersson L, Tsirk A, Ford J, Wu G, Kneller S,
Davies J, Duncan R (2005) PEG-doxorubicin conjugates: influence of polymer structure on drug
release, in vitro cytotoxicity, biodistribution, and antitumor activity. Bioconjug Chem 16:775-784
30. Pinholt C, Bukrinsky JT, Hostrup S, Frokjaer S, Norde W, Jorgensen L (2011) Influence of
PEGylation with linear and branched PEG chains on the adsorption of glucagon to hydropho-
bic surfaces. Eur J Pharm Biopharm 77:139-147
31. Somack R, Saifer MG, Williams LD (1991) Preparation of long-acting superoxide dismutase
using high molecular weight polyethylene glycol (41,000-72,000 daltons). Free Radic Res
Commun 12-13:553-562
32. Knauf MJ, Bell DP, Hirtzer P, Luo ZP, Young JD, Katre NV (1988) Relationship of effective
molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified
with water-soluble polymers. J Biol Chem 263:15064-15070
33. Brandenberger C, Muhlfeld C, Ali Z, Lenz AG, Schmid O, Parak WJ, Gehr P, Rothen-
Rutishauser B (2010) Quantitative evaluation of cellular uptake and trafficking of plain and
polyethylene glycol-coated gold nanoparticles. Small 6:1669-1678
34. Robers MJ, Harris JM (1998) Attachment of degradable Poly(ethylene glycol) to proteins has
the potential to increase therapeutic efficacy. J Pharm sci 11:1440-1445
35. Peleg-Shulman T, Tsubery H, Mironchik M, Fridkin M, Schreiber G, Shechter Y (2004)
Reversible PEGylation: a novel technology to release native interferon alpha2 over a
prolonged time period. J Med Chem 47:4897-4904
36. Zalipsky S, Qazen M, Walker JA 2nd, Mullah N, Quinn YP, Huang SK (1999) New detachable
poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phos-
pholipid, diacyl phosphatidylethanolamine. Bioconjug Chem 10:703-707
37. Filpula D, Zhao H (2008) Releasable PEGylation of proteins with customized linkers. Adv
Drug Deliv Rev 60:29-49
38. Yatuv R, Robinson M, Dayan I, Baru M (2010) Enhancement of the efficacy of therapeutic
proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF. Expert
Opin Drug Deliv 7:187-201
39. Hatakeyama H, Akita H, Harashima H (2011) A multifunctional envelope type nano device
(MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the
PEG dilemma. Adv Drug Deliv Rev 63:152-160
